Atlas Trials

Neuroblastoma Recurrent

13 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Neuroblastoma Recurrent

RecordFirmDate
Quadruple Immunotherapy for Neuroblastoma (NCT05754684)Hong Kong Children's Hospital2022-01-01
177Lutetium-DOTATATE in Children With Primary Refractory or Relapsed High-risk Neuroblastoma (NCT04903899)Jakob Stenman2021-05-19
9-ING-41 in Pediatric Patients With Refractory Malignancies. (NCT04239092)Actuate Therapeutics Inc.2020-06-05
Anti-GD2 CAR T Cells in Pediatric Patients Affected by High Risk and/or Relapsed/Refractory Neuroblastoma or Other GD2-positive Solid Tumors (NCT03373097)Bambino Gesù Hospital and Research Institute2018-01-05
Immunotherapy of Neuroblastoma Patients Using a Combination of Anti-GD2 and NK Cells (NCT03242603)National University Hospital, Singapore2017-10-03
Multimodal Molecular Targeted Therapy to Treat Relapsed or Refractory High-risk Neuroblastoma (NCT01467986)University of Regensburg2013-08-01
CH14.18 1021 Antibody and IL2 After Haplo SCT in Children With Relapsed Neuroblastoma (NCT02258815)University Children's Hospital Tuebingen2010-08-01
Fecal Microbiota Transplant for Neuroblastoma in a Single Patient (NCT07223606)ProgenaBiome

Track Neuroblastoma Recurrent automatically

Every clearance here is in the API, with alerts when new ones post.